Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fulvestrant Safety in Advanced Breast Cancer
NCT02447328Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- May 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fulvestrant in breast cancer, sponsored by AstraZeneca. Started May 2015; status: completed.
02
Drugs
fulvestrant
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02447328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02447328.